The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase II/III trial of conventional paclitaxel and carboplatin with/without bevacizumab versus dose-dense paclitaxel and carboplatin with/without bevacizumab, in stage IVB, recurrent, or persistent cervical carcinoma (JCOG1311): Results of the phase II part.
 
Mitsuya Ishikawa
No Relationships to Disclose
 
Ryo Kitagawa
No Relationships to Disclose
 
Taro Shibata
No Relationships to Disclose
 
Hideki Tokunaga
No Relationships to Disclose
 
Takashi Iwata
No Relationships to Disclose
 
Shin Nishio
No Relationships to Disclose
 
Toshio Takada
No Relationships to Disclose
 
Masahiko Mori
No Relationships to Disclose
 
Koji Horie
No Relationships to Disclose
 
Wataru Kudaka
No Relationships to Disclose
 
Masahiro Kagabu
No Relationships to Disclose
 
Michihiro Tanikawa
No Relationships to Disclose
 
Hiroaki Kobayashi
No Relationships to Disclose
 
Nobuo Yaegashi
No Relationships to Disclose